`
`EXHIBIT 2042
`
`Share of Wholesale Dollar Sales 100%
`
`90%
`
`80%
`
`70%
`
`60%
`
`50%
`
`40%
`
`30%
`
`20%
`
`Tea
`
`0%
`
`6.1%
`
`2007
`
`2006
`
`i Paya
`
`ear
`
`39.7%
`
`PTR
`
`RCE
`
`12.1%
`
`Ae
`
`2008
`
`2009
`
`2010
`
`2011
`
`2012
`
`2013
`
`2014
`
`2015
`
`2016
`
`2017
`
`BTRAVATAN Z® S@ TRAVATAN® SLUMIGAN® B8ZIOPTAN™ @&XALATAN® S RESCULA® ®Latanoprost ®Travoprost ®Bimatoprost
`
`[QVIA
`Source:
`Note: TRAVATAN Z® was launched in October 2006. Data for 2017 are available through October. The values for November and December 2017 are
`projected on the basis of the average yearly proportion of the wholesale dollar sales in November and December for the previous three years. For bimatoprost,
`the values for November and December 2017 are projected on the basis of the proportion of the wholesale dollar sales in November and December for the
`previous year.
`
`CONFIDENTIAL-PROTECTIVE ORDER MATERIAL
`
`ALCON 2042
`Argentum Pharm. LLC v. Alcon Research, Ltd.
`Case IPR2017-01053
`
`